Research-for-Cure Academy

Gabriela Turk

Nationality: Argentina
Institution: Instituto Investigaciones Biomédicas en Retrovirus y SIDA INBIRS
Country of work: Argentina

What is your motivation for engaging in HIV cure and remission research?

I have worked in the HIV field since 2001. I have witnessed the terrific advances made in our understanding of HIV pathogenesis, and the improvements experienced by PLHIV in terms of their access to therapy and quality of life. Indeed, I find the dynamics of this field extremely motivating. Even though a lot remains to be optimized, particularly in resource-constrained settings and in vulnerable populations, I consider that it is time we start paving the way for next-generation HIV cure research in Latin America.

What is your current area of research?

My primary area of interest is related to basic research. Particularly, I have been always captivated by the interplay between host immunity and persistent viruses. My research work is focused on the characterization of HIV-specific T-cell responses to dissect the mechanisms of protective responses and its relationship with the composition of the viral reservoir. Besides, we study the impact of CD74/MIF interaction on HIV pathogenesis and persistence. Finally, I am involved in a research project aimed at evaluating the impact of coinfections on the dynamics of the HIV viral reservoir to determine if they constitute a barrier for HIV cure.